Blog

17 Articles

Dr. Gulam Manji
Research
February 23, 2024 • 5 Min

Chemotherapy Plus Immunotherapy Trial Shows Promise

Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.

T lymphocyte in red on dark background
Research
December 21, 2022 • 2 Min

Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer

Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.

Dr. Allyson Ocean
Research
June 6, 2022 • 5 Min

Surprising Clinical Trial Results in Pancreatic and Rectal Cancer

Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.

Dr. Elizabeth Jaffee
Research
November 4, 2021 • 5 Min

New Clinical Accelerator Initiative Shortens Time from Bench to Clinic

Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.

vaccine vial and syringe
Research
October 27, 2021 • 2 Min

A Vaccine To Boost Immune Response to Pancreatic Cancer

Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.

Dr. William Freed-Pastor
Research
October 22, 2021 • 6 Min

Triple Immunotherapy Shows Dramatic Results

Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.

Research
June 21, 2021 • 3 Min

CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers

CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.

Dr. Beatriz Carreno
Research
April 16, 2020 • 5 Min

Targeting Mutant KRAS with Immunotherapy

Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos
Research
March 23, 2020 • 6 Min

Challenge Grant Recipients Moving Forward

The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.

Killer T cells
Research
September 10, 2019 • 4 Min

CAR T Cell Trial Targets Mesothelin

In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.

Dr. Vinod Balachandran
Research
March 13, 2019 • 5 Min

Pancreatic Cancer Exceptional Responders and the Immune System Link

Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.

Deirdre Cohen
Research
December 17, 2018 • 4 Min

Aiming to Improve Immunotherapy for Pancreatic Cancer

Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.

Dr. Ben Z. Stanger
Research
August 24, 2018 • 5 Min

New Research Sheds Light on Hot and Cold Tumors

Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.

Researcher Douglas Fearon
Research
May 14, 2018 • 3 Min

Immunology Researchers Solve a Mystery of Metastasis

Physician and researcher Douglas Fearon and his lab have a possible explanation for how cancer cells metastasize, and the role surgery may play in this process.

Dr. Vinod Balachandran
Research
January 16, 2018 • 3 Min

Neoantigens Provide New Hope for Pancreatic Cancer Treatments

Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.

  • 1
  • 2